Abstract
This study aimed to investigate the acute modulatory effect of bromazepam, a benzodiazepine derivative drug, on alpha and beta bands (8-35Hz) in primary motor areas (M1) through event-related spectral perturbation (ERSP). Ten healthy subjects were submitted to a cross-over double-blind design. Subjects performed a visuomotor task where they had to identify rapidly the ball launched horizontally and catch it quickly, while electroencephalographic activity was acquired. We found a statistically significant difference on the time windows of 2920 ms for 13Hz in the electrodes C3 and Cz, and on the time window of 2000 ms for 18Hz in the electrodes C3, when compared the bromazepam and placebo conditions. We concluded that the acute effects of bromazepam provoked changes in information process in the left M1 represented by electrode C3 in both 13 Hz and 18 Hz. Our paradigm is relevant for a better understanding of the brain dynamics due to the information related to bromazepam effects on sensorimotor processes. We consider this report an invitation to conduct more studies in order to associate electro-cortical activity and psychometric tests.
Keywords: EEG, ERSP, Bromazepam, Catching, Sensorimotor integration, visuomotor task, quantitative electroencephalography, EMG, electromyography, benzodiazepine, Ball acquisition
CNS & Neurological Disorders - Drug Targets
Title: Bromazepam Impairs Motor Response: An ERSP Study
Volume: 10 Issue: 8
Author(s): Julio G. Silva, Oscar Arias-Carrion, Flavia Paes, Bruna Velasques, Silmar Teixeira, Luis F. H. Basile, Mauricio Cagy, Roberto Piedade, Antonio E. Nardi, Sergio Machado and Pedro Ribeiro
Affiliation:
Keywords: EEG, ERSP, Bromazepam, Catching, Sensorimotor integration, visuomotor task, quantitative electroencephalography, EMG, electromyography, benzodiazepine, Ball acquisition
Abstract: This study aimed to investigate the acute modulatory effect of bromazepam, a benzodiazepine derivative drug, on alpha and beta bands (8-35Hz) in primary motor areas (M1) through event-related spectral perturbation (ERSP). Ten healthy subjects were submitted to a cross-over double-blind design. Subjects performed a visuomotor task where they had to identify rapidly the ball launched horizontally and catch it quickly, while electroencephalographic activity was acquired. We found a statistically significant difference on the time windows of 2920 ms for 13Hz in the electrodes C3 and Cz, and on the time window of 2000 ms for 18Hz in the electrodes C3, when compared the bromazepam and placebo conditions. We concluded that the acute effects of bromazepam provoked changes in information process in the left M1 represented by electrode C3 in both 13 Hz and 18 Hz. Our paradigm is relevant for a better understanding of the brain dynamics due to the information related to bromazepam effects on sensorimotor processes. We consider this report an invitation to conduct more studies in order to associate electro-cortical activity and psychometric tests.
Export Options
About this article
Cite this article as:
G. Silva Julio, Arias-Carrion Oscar, Paes Flavia, Velasques Bruna, Teixeira Silmar, F. H. Basile Luis, Cagy Mauricio, Piedade Roberto, E. Nardi Antonio, Machado Sergio and Ribeiro Pedro, Bromazepam Impairs Motor Response: An ERSP Study, CNS & Neurological Disorders - Drug Targets 2011; 10 (8) . https://dx.doi.org/10.2174/187152711799219361
DOI https://dx.doi.org/10.2174/187152711799219361 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Editorial Board Member
Current Alzheimer Research Trans-diagnostic Validation in Neuro-psychiatry: Towards Biological Signatures of Disease
Current Topics in Medicinal Chemistry Biological Function and Mechanism of Bone Marrow Mesenchymal Stem Cells-packed Poly (3,4-ethylenedioxythiophene) (PEDOT) Scaffolds for Peripheral Nerve Injury: The Involvement of miR-21-Notch Signaling Pathway
Current Neurovascular Research Discovery of MAO-B Inhibitors - Present Status and Future Directions Part I: Oxygen Heterocycles and Analogs
Mini-Reviews in Medicinal Chemistry Possibility that the Onset of Autism Spectrum Disorder is Induced by Failure of the Glutamine-Glutamate Cycle
Current Molecular Pharmacology Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases
Current Pharmaceutical Design Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Application of the O-N Intramolecular Acyl Migration Reaction in Medicinal Chemistry
Current Medicinal Chemistry Editorial: [Hot Topic: Therapeutic Antioxidants for Neurodegenerative Disease]
Recent Patents on CNS Drug Discovery (Discontinued) Conference Report
CNS & Neurological Disorders - Drug Targets Recent Developments of Platinum-based Anticancer Drugs- Detection and Analysis in Biological Samples
Current Organic Chemistry Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer’s Diseases
Current Alzheimer Research Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring
Current Molecular Medicine Lessons from Darwin: 21st Century Designs for Clinical Trials
Current Alzheimer Research Blood-brain Barrier Disruption Leads to Postoperative Cognitive Dysfunction
Current Neurovascular Research Neuronal Semaphorins Regulate a Primary Immune Response
Current Neurovascular Research The Role of Lifestyle Change in the Prevention and Treatment of NAFLD
Current Pharmaceutical Design Nuezhenide Exerts Anti-Inflammatory Activity through the NF-κB Pathway
Current Molecular Pharmacology Ontogeny of Human Conjugating Enzymes
Drug Metabolism Letters Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Dev elopment (Part C))
Current Pharmaceutical Design